Hrt Financial LP Roivant Sciences Ltd. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$8.38 - $11.58 $1.45 Million - $2 Million	173,103 New	173,103 $1.94 Million
Q2 2023 Aug 11, 2023	BUY	$7.09 - $10.08 $4.51 Million - $6.41 Million	635,470 New	635,470 $6.41 Million
Q3 2022 Nov 14, 2022	BUY	$0.51 - $4.84 $89,359 - $848,040	175,215 Added 59.09%	471,738 $1.52 Million
Q2 2022 Aug 12, 2022	BUY	$2.81 - $4.84 $158,245 - $272,564	56,315 Added 23.44%	296,523 $1.21 Million
Q1 2022 May 16, 2022	BUY	$4.74 - $9.91 $1.14 Million - $2.38 Million	240,208 New	240,208 $1.19 Million

308

496M

989K

1.15M

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.49B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.